Research Output per year
The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemiaMahipal, A. & Weiss, M., Nov 1 2010, In : Current Oncology Reports. 12, 6, p. 352-354 3 p.
Research output: Contribution to journal › Comment/debate
B-Cell Chronic Lymphocytic Leukemia